Skip to main content
Clinical Trials/NCT03209544
NCT03209544
Completed
N/A

A Randomized Controlled Trial on the Effectiveness of an Online Self-help Intervention for Suicidal Ideation

University Ghent0 sites724 target enrollmentApril 23, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Suicidal Ideation
Sponsor
University Ghent
Enrollment
724
Primary Endpoint
Beck Scale for Suicide Ideation
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The objective of the Think Life study is to test the effect of an online, unguided self-help intervention, i.e. Think Life. The primary hypothesis is that Think Life will reduce suicidal ideation. The secondary hypothesis is that Think Life will lead to improvements in depressive symptoms, hopelessness, rumination, and anxiety. Positive changes are expected after completing Think Life and at follow-up, twelve weeks after baseline.

Registry
clinicaltrials.gov
Start Date
April 23, 2015
End Date
February 24, 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years or older
  • Have internet access and an e-mail account

Exclusion Criteria

  • No suicidal thoughts (i.e. baseline score on Beck Scale for Suicide Ideation = 0)

Outcomes

Primary Outcomes

Beck Scale for Suicide Ideation

Time Frame: Baseline, and 2, 4, 6 (post-test) and 12 weeks (follow-up) after baseline

Changes in severity of suicidal ideation

Secondary Outcomes

  • Beck Hopelessness Scale(Baseline, and 6 (post-test) and 12 weeks (follow-up) after baseline)
  • Beck Depression Inventory - second edition(Baseline, and 2, 4, 6 (post-test) and 12 weeks (follow-up) after baseline)
  • Hospital Anxiety and Depression Scale(Baseline, and 6 (post-test) and 12 weeks (follow-up) after baseline)
  • Suicidal Ideation Attributes(Baseline, and 2, 4, 6 (post-test) and 12 weeks (follow-up) after baseline)
  • Penn State Worry Questionnaire - Past Week(Baseline, and 6 (post-test) and 12 weeks (follow-up) after baseline)

Similar Trials